Class II
Terminated
My Way (Levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg Levonorgestrel Tablets) per carton, GAVIS Pharmaceuticals, A Lupin Group Company; Mfg.
Why: Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.
- Company
- Lupin Pharmaceuticals Inc.
Baltimore, MD, United States - Reported
- May 30, 2018
- Recall started
- May 17, 2018
- Ended
- May 1, 2019
- Where sold
- Nationwide in the USA
- Amount
- 43,922 cartons
- Full product description
- My Way (Levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg Levonorgestrel Tablets) per carton, GAVIS Pharmaceuticals, A Lupin Group Company; Mfg. for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, UPC 3 43386-622-31 3.
- Lots / codes affected
- Lot #: M16317A1, M16317A4, M16317A5, Exp 11/18
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.